Vaxart (VXRT) Competitors

→ “Forget Tesla, this is Elon’s Next Big Thing” (From InvestorPlace) (Ad)

$0.91

0.00 (0.00%)

(As of 04/15/2024 ET)

VXRT vs. SGMT, ZVRA, KPTI, KNTE, ATHA, SPRO, INO, CMRX, ALGS, and RNAC

Should you be buying Vaxart stock or one of its competitors? The main competitors of Vaxart include Sagimet Biosciences (SGMT), Zevra Therapeutics (ZVRA), Karyopharm Therapeutics (KPTI), Kinnate Biopharma (KNTE), Athira Pharma (ATHA), Spero Therapeutics (SPRO), Inovio Pharmaceuticals (INO), Chimerix (CMRX), Aligos Therapeutics (ALGS), and Cartesian Therapeutics (RNAC). These companies are all part of the "medical" sector.

Vaxart vs.

Vaxart (NASDAQ:VXRT) and Sagimet Biosciences (NASDAQ:SGMT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, community ranking, analyst recommendations, risk, profitability and earnings.

: Sagimet Biosciences has a net margin of 0.00% compared to Vaxart's net margin of -1,117.56%. Sagimet Biosciences' return on equity of 0.00% beat Vaxart's return on equity.
Company Net Margins Return on Equity Return on Assets
Vaxart -1,117.56% -108.45% -73.31%
Sagimet Biosciences N/A N/A N/A
: 18.0% of Vaxart shares are owned by institutional investors. Comparatively, 87.9% of Sagimet Biosciences shares are owned by institutional investors. 3.0% of Vaxart shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
: Vaxart received 298 more outperform votes than Sagimet Biosciences when rated by MarketBeat users. However, 100.00% of users gave Sagimet Biosciences an outperform vote while only 65.47% of users gave Vaxart an outperform vote.
Company Underperform Outperform
Vaxart Outperform Votes
309
65.47%
Underperform Votes
163
34.53%
Sagimet Biosciences Outperform Votes
11
100.00%
Underperform Votes
No Votes
: Sagimet Biosciences has lower revenue, but higher earnings than Vaxart.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Vaxart $7.38M 21.42 -$82.46M -$0.58 -1.57
Sagimet Biosciences $2M 72.76 -$27.88M N/A N/A
: In the previous week, Sagimet Biosciences had 1 more articles in the media than Vaxart. MarketBeat recorded 3 mentions for Sagimet Biosciences and 2 mentions for Vaxart. Vaxart's average media sentiment score of 1.44 beat Sagimet Biosciences' score of 0.94 indicating that Vaxart is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vaxart
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sagimet Biosciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: Vaxart presently has a consensus price target of $3.00, indicating a potential upside of 230.00%. Sagimet Biosciences has a consensus price target of $41.50, indicating a potential upside of 810.09%. Given Sagimet Biosciences' higher probable upside, analysts plainly believe Sagimet Biosciences is more favorable than Vaxart.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vaxart
0 Sell rating(s)
0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
3.00
Sagimet Biosciences
0 Sell rating(s)

0 Hold rating(s)

6 Buy rating(s)

0 Strong Buy rating(s)
3.00

Company	Net Margins	Return on Equity	Return on Assets
Vaxart	-1,117.56%	-108.45%	-73.31%
Sagimet Biosciences	N/A	N/A	N/A

Company	Underperform	Outperform
Vaxart	Outperform Votes 309 65.47%	Underperform Votes 163 34.53%
Sagimet Biosciences	Outperform Votes 11 100.00%	Underperform Votes No Votes

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vaxart	$7.38M	21.42	-$82.46M	-$0.58	-1.57
Sagimet Biosciences	$2M	72.76	-$27.88M	N/A	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vaxart	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sagimet Biosciences	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vaxart	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Sagimet Biosciences	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Sagimet Biosciences beats Vaxart on 10 of the 14 factors compared between the two stocks.

Ad TradeSmith

A.I. Pioneer Issues Urgent Warning to Americans

With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future? It's the question on many of our minds.

Click here to see Louis' new video for yourself.

Get Vaxart News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VXRT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VXRT vs. The Competition

Export to Excel

Metric	Vaxart	Biological Products Industry	Medical Sector	NASDAQ Exchange
Market Cap	$158.06M	$2.57B	$4.66B	$7.47B
Dividend Yield	N/A	2.27%	5.46%	3.95%
P/E Ratio	-1.57	25.94	208.85	16.55
Price / Sales	21.42	319.46	2,422.69	90.74
Price / Cash	N/A	139.56	32.96	28.17
Price / Book	2.39	3.85	4.66	4.46
Net Income	-$82.46M	-$45.15M	$99.18M	$210.28M
7 Day Performance	-15.82%	-5.77%	-4.39%	-3.69%
1 Month Performance	-15.82%	-4.93%	-2.84%	0.52%
1 Year Performance	38.37%	11.28%	12.37%	7.13%

Vaxart Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SGMT Sagimet Biosciences	2.3513 of 5 stars	$5.31 -1.3%	$41.50 +681.5%	N/A	$169.44M	$2M	0.00	8	Short Interest ↑ Positive News
ZVRA Zevra Therapeutics	1.1017 of 5 stars	$4.73 -4.3%	$19.50 +312.3%	-23.8%	$205.42M	$27.46M	-3.67	32
KPTI Karyopharm Therapeutics	3.8232 of 5 stars	$1.34 -0.7%	$5.67 +322.9%	-73.3%	$154.19M	$146.03M	-1.07	325	Negative News
KNTE Kinnate Biopharma	4.7486 of 5 stars	$2.65 -0.4%	$11.72 +342.2%	-51.5%	$125.13M	N/A	-0.95	84	High Trading Volume
ATHA Athira Pharma	2.3476 of 5 stars	$2.52 +4.1%	$12.00 +376.2%	-19.8%	$96.59M	N/A	-0.82	65	News Coverage
SPRO Spero Therapeutics	4.6269 of 5 stars	$1.69 +0.6%	$7.00 +314.2%	-11.0%	$91.04M	$103.78M	4.02	46	Positive News
INO Inovio Pharmaceuticals	3.4123 of 5 stars	$11.63 +2.6%	$96.00 +725.5%	-91.0%	$271.79M	$832,010.00	-1.54	122	News Coverage
CMRX Chimerix	4.341 of 5 stars	$0.99 -1.0%	$8.00 +708.1%	-23.8%	$88.32M	$320,000.00	-1.08	72	News Coverage Positive News
ALGS Aligos Therapeutics	2.4205 of 5 stars	$1.06 -0.9%	N/A	-3.8%	$80.21M	$15.53M	-0.67	66	Gap Down
RNAC Cartesian Therapeutics	3.3885 of 5 stars	$13.99 +6.6%	$60.00 +328.9%	N/A	$75.41M	$26M	0.00	37	Stock Split Positive News Gap Up

Related Companies and Tools

Related Companies:

Top 10 Stock Comparisons

This page (NASDAQ:VXRT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Vaxart (VXRT) Competitors

VXRT vs. SGMT, ZVRA, KPTI, KNTE, ATHA, SPRO, INO, CMRX, ALGS, and RNAC

Vaxart vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VXRT vs. The Competition

Vaxart Competitors List

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info